Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Imiquimod (Primary) ; Peptide vaccines (Primary)
- Indications Ependymoma
- Focus Adverse reactions; Biomarker
- 05 Aug 2021 Biomarkers information updated
- 28 Feb 2013 New trial record